Highlights and Quick Summary
- Liabilities (Preferred Stock) for the quarter ending December 31, 2018 was $210 Million
- Annual Liabilities (Preferred Stock) for 2018 was $210 Million
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Liabilities (Preferred Stock) of Atreca, Inc.
Most recent Liabilities (Preferred Stock)of BCEL including historical data for past 10 years.Interactive Chart of Liabilities (Preferred Stock) of Atreca, Inc.
Atreca, Inc. Liabilities (Preferred Stock) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2018 | $210.05 | – | – | – | $210.05 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology